New drugs are unsustainably expensive

Researchers from Oxford University say that the development of new drugs has become unsustainably expensive due to misguided research practices. Dr Jack Scannell and consultant Jim Bosley from Oxford and UCL’s Centre for the Advancement of Sustainable Medical Innovation presented their findings in a paper for scientific journal PLOS ONE, entitled ‘When Quality Beats Quantity: […]

Continue Reading